Hyderabad: Pharma player Granules India Limited on Thursday said a packaging facility of its US step-down subsidiary, ...

Granules India's U.S. packaging facility passes FDA inspection with zero observations, ensuring compliance for OTC and controlled substances.

Granules India announced that its US step-down subsidiary, Granules Consumer Health, LLC, a wholly-owned subsidiary of Granules Pharmaceuticals, Inc., successfully completed a GMP inspection by the U.

Granules India’s US packaging facility passes FDA inspection with zero observations, emphasising quality and regulatory ...

Ahmedabad: Zydus has announced that the company has received the Establishment Inspection Report (EIR) from the U.S. Food and ...

WUXI, China, Oct. 27, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed a remote GMP ...

It is very important for pharmaceutical companies to plan carefully for all Good Manufacturing Practice (GMP) inspections, as a successful outcome is required for continued operations. Careful ...

Zydus Lifesciences' Vadodara injectable facility receives U.S. FDA inspection report with VAI status following a recent GMP review.

On 4 March 2017, the agreement between the EU and the US governing the reciprocal recognition of GMP inspections of manufacturing sites for medicinal products for human use was published in the ...

SHANGHAI, China, Feb. 23 /PRNewswire-Asia/ -- WuXi PharmaTech ( WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China ...